Patients with symptomatic intracranial atherosclerosis who show impaired distal perfusion face a significantly higher risk for early stroke recurrence.
Stockhead on MSN
New preclinical study validates efficacy dose of Argenica’s stroke treatment candidate
Argenica Therapeutics has taken a step forward in the development of its neuroprotective drug candidate ARG-007 in acute ...
5don MSN
Concordia researchers identify key marker linking coronary artery disease to cognitive decline
A new model combining a dozen metrics measures differences in white matter structure between older CAD patients and healthy ...
News-Medical.Net on MSN
White matter alterations connect coronary artery disease to cognitive decline
Individuals with coronary artery disease (CAD) - a constricting or blocking of blood vessels feeding the heart - face ...
Argenica Therapeutics (ASX: AGN) has released new data from an independent pre-clinical study validating the efficacy and ...
A new study has found that people with coronary artery disease (CAD) may experience changes in their brain’s white matter ...
Verywell Health on MSN
Stroke vs. Heart Attack: How to Tell the Difference
Stroke and heart attack are life-threatening conditions that require emergency medical attention, but they differ in the affected organ and symptoms.
A heart attack and stroke are both medical emergencies caused by sudden disruption of blood flow, but they affect different ...
Diagnostic Challenges in Low-Resource Settings —A Six-Case Series. Neuroscience and Medicine, 16, 221-233. doi: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback